pubmed-article:8315960 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8315960 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
pubmed-article:8315960 | lifeskim:mentions | umls-concept:C0041296 | lld:lifeskim |
pubmed-article:8315960 | lifeskim:mentions | umls-concept:C0009247 | lld:lifeskim |
pubmed-article:8315960 | lifeskim:mentions | umls-concept:C0700285 | lld:lifeskim |
pubmed-article:8315960 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:8315960 | lifeskim:mentions | umls-concept:C0009462 | lld:lifeskim |
pubmed-article:8315960 | lifeskim:mentions | umls-concept:C0598281 | lld:lifeskim |
pubmed-article:8315960 | lifeskim:mentions | umls-concept:C1518896 | lld:lifeskim |
pubmed-article:8315960 | pubmed:issue | 19 | lld:pubmed |
pubmed-article:8315960 | pubmed:dateCreated | 1993-7-23 | lld:pubmed |
pubmed-article:8315960 | pubmed:abstractText | The aim of this study was to determine the risk of active tuberculosis in intravenous drug addict (IVDA) patients seropositive and seronegative for the HIV. | lld:pubmed |
pubmed-article:8315960 | pubmed:language | spa | lld:pubmed |
pubmed-article:8315960 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8315960 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8315960 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8315960 | pubmed:month | May | lld:pubmed |
pubmed-article:8315960 | pubmed:issn | 0025-7753 | lld:pubmed |
pubmed-article:8315960 | pubmed:author | pubmed-author:LópezEE | lld:pubmed |
pubmed-article:8315960 | pubmed:author | pubmed-author:VergaraLL | lld:pubmed |
pubmed-article:8315960 | pubmed:author | pubmed-author:SoleraJJ | lld:pubmed |
pubmed-article:8315960 | pubmed:author | pubmed-author:VEERR ARA | lld:pubmed |
pubmed-article:8315960 | pubmed:author | pubmed-author:Martínez-Alfa... | lld:pubmed |
pubmed-article:8315960 | pubmed:author | pubmed-author:SernaEE | lld:pubmed |
pubmed-article:8315960 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8315960 | pubmed:day | 15 | lld:pubmed |
pubmed-article:8315960 | pubmed:volume | 100 | lld:pubmed |
pubmed-article:8315960 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8315960 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8315960 | pubmed:pagination | 725-9 | lld:pubmed |
pubmed-article:8315960 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:meshHeading | pubmed-meshheading:8315960-... | lld:pubmed |
pubmed-article:8315960 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:8315960 | pubmed:articleTitle | [Risk of tuberculosis in parenteral drug addicts with human immunodeficiency virus seropositivity. A cohort study in detoxication communities]. | lld:pubmed |
pubmed-article:8315960 | pubmed:affiliation | Unidad de Enfermedades Infecciosas, Hospital General de Albacete. | lld:pubmed |
pubmed-article:8315960 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8315960 | pubmed:publicationType | English Abstract | lld:pubmed |